NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Reckitt Benckiser Group plc ("Reckitt" or the "Company") (OTC:RBGLY) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired Reckitt securities between January 13, 2021, and July 28, 2024, both dates inclusive (the "Class Period"). I ...

Core Viewpoint - Reckitt Benckiser Group PLC is facing a class action lawsuit from investors due to alleged misleading statements and failure to disclose health risks associated with its Enfamil infant formula, leading to significant stock price declines [3][4][5]. Group 1: Class Action Details - The class action represents investors who purchased Reckitt Benckiser securities between January 13, 2021, and July 28, 2024, with a deadline for filing a lead plaintiff motion set for August 4, 2025 [1]. - The lawsuit claims that Reckitt Benckiser did not adequately warn consumers and investors about the increased risk of Necrotizing Enterocolitis (NEC) for preterm infants consuming its cow's milk-based formula [3]. Group 2: Legal Outcomes and Financial Impact - A jury verdict on March 15, 2024, found Mead Johnson negligent, resulting in a $60 million award for failing to warn about NEC risks, which caused Reckitt Benckiser's American Depositary Shares (ADSs) to drop nearly 14% [4]. - Following a related case on July 29, 2024, where a Missouri jury awarded $495 million in damages over NEC caused by a competing formula, Reckitt Benckiser's ADSs fell nearly 9% [5].

NEW YORK, July 28, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Reckitt Benckiser Group plc (OTCQX: RBGLY).Shareholders who purchased shares of RBGLY during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/reckitt-benckiser-group-plc-loss-submission-form-2/?id=158119&from=4CLASS PE ...

NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Reckitt Benckiser Group plc ("Reckitt Benckiser Group plc" or the "Company") (OTCQX: RBGLY) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Reckitt Benckiser Group plc investors who were adversely affected by alleged securities fraud between January 13, 2021 and July 28, 2024. Follow the link below to get more information and be contacted by a member of our team: h ...

NEW YORK, July 25, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Reckitt Benckiser Group plc ("Reckitt Benckiser Group plc" or the "Company") (OTCQX: RBGLY) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Reckitt Benckiser Group plc investors who were adversely affected by alleged securities fraud between January 13, 2021 and July 28, 2024. Follow the link below to get more information and be contacted by a member of our team:https:/ ...

NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Reckitt Benckiser Group plc (OTCQX: RBGLY). Shareholders who purchased shares of RBGLY during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/reckitt-benckiser-group-plc-loss-submission-form-2/?id=157780&from=3 ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Reckitt Benckiser Group plc regarding a class action lawsuit alleging that the company made materially false and misleading statements about its cow's milk-based formula, Enfamil, which is linked to increased risks for preterm infants [1][2]. Group 1: Allegations and Class Period - The class period for the allegations is from January 13, 2021, to July 28, 2024 [1]. - The allegations include that Reckitt failed to disclose the increased risk of necrotizing enterocolitis (NEC) for preterm infants consuming Enfamil, which could impact sales and expose the company to legal claims [1]. Group 2: Next Steps for Shareholders - Shareholders are encouraged to register for the class action by August 4, 2025, to potentially be appointed as lead plaintiffs [2]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the status of the case [2]. Group 3: Firm's Mission - The Gross Law Firm aims to protect investors' rights against deceit and illegal business practices, ensuring companies adhere to responsible business practices [3].

Reckitt Benckiser expects higher revenue growth from its core brands this year, and kicked off a £1 billion share buyback https://t.co/EGieP2JAGU ...

Core Viewpoint - Scott+Scott Attorneys at Law LLP has filed a securities class action lawsuit against Reckitt Benckiser Group PLC, alleging misleading statements regarding the risks associated with its cow's milk-based formula, Enfamil, during the Class Period from January 13, 2021, to July 28, 2024 [1][3]. Group 1: Lawsuit Details - The lawsuit asserts claims under the Securities Exchange Act of 1934, specifically §§10(b) and 20(a), on behalf of individuals who purchased Reckitt American Depositary Shares (ADSs) during the Class Period [1]. - The case is titled Elevator Constructors Union Local No. 1 Annuity & 401(K) Fund v. Reckitt Benckiser Group PLC, et al., Case No. 1:25-cv-4708 [1]. Group 2: Allegations Against Reckitt - The Class Action alleges that Reckitt failed to disclose that preterm infants consuming its Enfamil formula were at an increased risk of developing necrotizing enterocolitis (NEC) [3]. - It is claimed that Reckitt did not adequately warn investors about the potential impact on sales and legal exposure related to the NEC risk [3]. Group 3: Market Reactions - On March 15, 2024, following a jury verdict in a related NEC lawsuit, Reckitt's ADS price fell by $1.87, or nearly 14%, from $13.31 to $11.44 per share [4]. - On July 29, 2024, after another jury verdict against Abbott Laboratories regarding NEC, Reckitt's ADS price dropped by $1.02, or nearly 9%, from $11.66 to $10.64 per share [5].

NEW YORK, July 22, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares ("ADSs") of Reckitt Benckiser Group PLC (OTC: RBGLY) between January 13, 2021 through July 28, 2024, both dates inclusive (the "Class Period"), of the important August 4, 2025 lead plaintiff deadline.So What: If you purchased Reckitt ADSs you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.What to ...